Session Details

S033 Vascular Anomalies Symposium: Classification, Clinical Challenges, and Management Update

Sat, Mar 8, 1:00 PM - 4:00 PM
W311E
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Dermatologists play a primary role in diagnosing and directing the management of vascular anomalies. Over the last decade there have been significant developments in the understanding of the pathogenesis of vascular anomalies which have impacted clinical practice. In this session, experts in the field will discuss key topics and literature relating to the evaluation and management of problematic infantile hemangiomas, capillary malformations and vascular anomalies.

LEARNING OBJECTIVES

1.

Examine published data from last year on management of infantile hemangiomas and vascular anomalies

2.

Develop tools for laser therapy and medical management of infantile hemangiomas and vascular anomalies

3.

Enhance knowledge of diagnostic criteria and imaging of high risk infantile hemangiomas and vascular anomalies.

SCHEDULE

6:00 PM

PHACE and LUMBAR syndromes; What’s New?

Denise W Metry, MD, FAAD

6:25 PM

Vascular Anomalies: Classification and Genetics

Eulalia Baselga Torres, MD, IFAAD

6:45 PM

Hemangioma Hot Topics

Christine T Lauren, MD, FAAD

7:05 PM

Panel Q and A

Eulalia Baselga Torres, MD, IFAAD, Christine T Lauren, MD, FAAD, Denise W Metry, MD, FAAD

7:25 PM

Targeted Therapies: The Highs, the Lows and What’s on the Horizon

Beth Ann Drolet, MD, FAAD

7:45 PM

Laser Modalities for Vascular Anomalies: Pearls and Principals

Deepti Gupta, MD

8:05 PM

Vascular Anomalies in the Literature: Year in Review

Maria Cecilia Garzon, MD, FAAD

8:25 PM

Panel Q and A

Eulalia Baselga Torres, MD, IFAAD, Beth Ann Drolet, MD, FAAD, Maria Cecilia Garzon, MD, FAAD

8:40 PM

Challenging Cases: Vascular Anomalies

Sheilagh M. Maguiness, MD, FAAD

SPEAKERS

Eulalia Baselga Torres, MD, IFAAD

Eulalia Baselga Torres, MD, IFAAD

Beth Ann Drolet, MD, FAAD

Beth Ann Drolet, MD, FAAD

Maria Cecilia Garzon, MD, FAAD

Maria Cecilia Garzon, MD, FAAD

Deepti Gupta, MD

Deepti Gupta, MD

Christine T Lauren, MD, FAAD

Christine T Lauren, MD, FAAD

Sheilagh M. Maguiness, MD, FAAD

Sheilagh M. Maguiness, MD, FAAD

Denise W Metry, MD, FAAD

Denise W Metry, MD, FAAD

SPEAKER DISCLOSURES

Eulalia Baselga Torres, MD, IFAAD

AbbVie – Investigator(Fees); Almirall – Speaker(Honoraria); Cytovation – Consultant(Fees); Demira – Investigator(Fees); Ferrer – Consultant(Honoraria), Speaker(Fees); Isdin – Speaker/Faculty Education(Honoraria); Martiderm – Speaker(Fees); Novartis – Other(Other Financial Benefit), Speaker(Fees); Pierre Fabre Dermatologie – Investigator(Honoraria), Speaker(Fees); Sanofi/Regeneron – Consultant(Fees); venthera – Founder(Stock Options);

Beth Ann Drolet, MD, FAAD

Arkayli Biosciences – Founder(Stock); Novartis Pharmaceuticals Corp. – Investigator(No Compensation Received);

Maria Cecilia Garzon, MD, FAAD

No financial relationships exist with ineligible companies.

Deepti Gupta, MD

No financial relationships exist with ineligible companies.

Christine T Lauren, MD, FAAD

No financial relationships exist with ineligible companies.

Sheilagh M. Maguiness, MD, FAAD

Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);

Denise W Metry, MD, FAAD

No financial relationships exist with ineligible companies.